AI Generated Image
Coroner Links California Law Student’s Death To Weight Loss Drug Tirzepatide
Yahoo • • health
Key Points:
- Josephine Nasr, a 19-year-old American law student in England, died from a heart rhythm disturbance linked to myocardial bridging and electrolyte imbalance caused by low blood sugar due to her prescription weight-loss medication tirzepatide.
- The coroner found that tirzepatide-induced nausea led to hypoglycemia and an electrolyte imbalance, triggering a dangerous arrhythmia that contributed to her sudden death.
- Nasr, described as an otherwise healthy young woman, experienced severe nausea and vomiting on the night of her death, prompting a welfare check after she stopped responding to contacts.
- Tirzepatide, marketed as Mounjaro and Zepbound, is approved for type 2 diabetes and weight management but carries warnings about serious gastrointestinal side effects and is not recommended for cosmetic use or patients under 18.
- Nasr's family remembered her as a joyful and caring individual, emphasizing her active lifestyle and love for travel and helping others.
